scott@vtx-cpd.com
Forum Replies Created
-
AuthorPosts
-
Replying to Sarah Clements 04/03/2024 - 09:44
Sarah!
Lovely to see you here. Thank you so much for your ongoing support.
Congratulation on the AP status! That is very exciting. I need to make sure I up my game! π
I really hope you enjoy the course.
Scott π
Replying to Junwei FΓΆhr 01/03/2024 - 20:19
Hello!
Really interesting question. I will look forward to hearing Jenny’s thoughts.
Scott π
Replying to Rachel L. 25/02/2024 - 18:42
Hello Rachel.
Me again. You have me down a polycythaemia rabbit hole.
I wanted to share this slightly unusual treatment strategy for polycythemia in a cat. I am absolutely not advocating doing this:
A novel bone marrow-sparing treatment for primary erythrocytosis in a cat: Onion powder
Primary erythrocytosis (PE) is a rare myeloproliferative neoplasm in cats resulting in the overproduction of erythrocytes. Current treatment modalities include repeated phlebotomy and chemotherapeutic drugs. These treatments may not be well tolerated by the cat and can present safety and financial challenges to owners. Because of the rarity of PE, prospective studies for new treatment options are difficult to perform. This case report describes the novel use of onion powder in an attempt to produce Heinz body-induced erythrocyte destruction in order to decrease total erythrocyte mass and normalize the hematocrit in a cat with PE. To our knowledge, the use of onion powder in the treatment of PE in cats has never been described before and may have potential as a safe, low-cost, and highly accessible alternative treatment for this rare disease.
The full paper can be accessed for free:
https://www.ncbi.nlm.nih.gov/pmc/articles/pmc8295705/
Thoughts on using toxicity as a therapeutic strategy!? Not for me!
Scott π
Hey Felipe!
Really interesting question. I look forward to hearing peoples thoughts.
Scott π
Replying to Felipe M. 26/02/2024 - 19:30
Hey Felipe.
It is s good point. I think there is some data showing some differences with arterial vs. venous overall. As you mentioned, the blood gas stuff would be the main thing.
https://pubmed.ncbi.nlm.nih.gov/16690335/
I think consistency is probably key when looking at serial samples.
Scott π
Replying to Rachel L. 25/02/2024 - 18:42
So interesting Rachel.
Thank you for sharing these cases. Both really interesting. These are cases you don’t see that often.
You made me think about the Dachshund! There are some interesting differences with their haematology that I will share!
Thanks for sparking such great discussion!
Scott π
Replying to Kasia K. 28/02/2024 - 09:51
Hello Kasia.
Sorry to hear some of the notes are cut off. I can send you a copy of the PDS slides again if that would help.
Drop me an email and I will see what I can do:
I hope you are enjoying the course!
Scott π
Replying to Rachel C. 28/02/2024 - 15:42
Thank you for the brilliant Question Rachel.
I will make sure Felipe see this. I look forward to hearing his thoughts.
Scott π
Replying to Rachel C. 28/02/2024 - 15:45
Welcome Rachel.
Great to have you join us! I am always so impressed that people are able to manage doing CPD while on maternity. Massive respect!
I really hope you enjoy the course. Please let me know if you have any questions.
Scott π
Replying to Junwei FΓΆhr 27/02/2024 - 16:43
No problem!
Let us know if you have any other questions!
Scott π
Replying to Kasia K. 26/02/2024 - 17:05
Hello Kasia.
Welcome! Thank you so much for joining the course and thank you so much for your brilliant questions! I will make sure the wonderful Neus and Kerry see them and we will get back to you ASAP.
Have a wonderful week.
Scott π
Replying to Christina L. 26/02/2024 - 17:58
Welcome Christina.
We are so pleased you have joined the course.
I really hope you enjoy it! Please let me know if you have any questions.
Scott π
Replying to Lauren B. 26/02/2024 - 15:51
Lauren!
Welcome. Thank you so much for joining us. I can guarantee that you are doing better than we are on Vancouver Island today. We have woken up to snow!
Please remember you can use the forum to ask questions at anytime.
Have a lovely week.
Scott π
Replying to Neus E. 16/02/2024 - 22:12
Really helpful Neus!
It is even better when you can reference yourself! π
I do not routenly in practice, but it is reassuring to hear your experience. I have popped the abstract to you papaer below.
Thanks again.
Scott π
Indications for use and complications associated with canine plasma products in 170 patients
Abstract
Objectives: To describe a population of dogs receiving canine plasma products (PP), report the incidence of transfusion reactions (TR), and to identify whether this is higher when non-type-matched plasma is administered.
Design: Retrospective study conducted on dogs receiving canine PP between March 2016 and January 2018.
Setting: Private referral hospital with first opinion emergency clinic.
Animals: One hundred and ninety-four privately owned dogs identified from the clinic electronic medical record system that received at least 1 unit of canine PP during the study period; 25 patients were excluded due to incomplete records.
Interventions: None.
Measurements and main results: A search of computerized records was performed, identifying any patients that received canine PP between 2016 and 2018; clinical notes were examined to identify the number and type of TR associated. One hundred and sixty-nine cases were included in the study, receiving a total of 412 PP transfusions. Reactions were noted in 4% (17/412) of transfusions administered, with the vast majority being mild in nature. Of the TR identified, a greater proportion were in type-matched PP transfusions than non-type-matched, although this difference was not statistically significant (P = 0.7989). The number of dogs suffering a TR was higher (13%) when multiple units of plasma were administered than if only 1 unit was transfused (5%), but this was not statistically significant (P = 0.1161). Transfusion reactions were more likely to occur when packed red blood cells were also administered, although this was also not statistically significant (P = 0.07).
Conclusion: Administration of canine plasma products appears to be a safe procedure that carries a low risk of transfusion reactions. Type-matching of canine PP appears unnecessary and does not reduce incidence of TR in dogs.
Replying to Junwei FΓΆhr 22/02/2024 - 22:24
Hello.
This could be a form of reverse sneezing, although it is not a totally ‘classic’ noise. It certainly sounds like it is coming from the naso-pharynx or the nasal cavity. The dog does seem to be gulping and salivating too. I would be worried this may have been triggered by a reflux event that has irritated the back of the throat.
Much of the investigation that I would recommend would depend on the persistence of the clinical signs. If the problem has subsided, I would not worry too much.
Hope that helps.
Scott π
-
AuthorPosts